Physician profile
Federico Auger
NPI 1881833382
$3,374.29
in general payments reported to CMS, 2019-2025
14 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2020: $154 · 2021: $288 · 2022: $388 · 2023: $789 · 2024: $244 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,084.50 | 2019-2025 | Augment Injectable, Allowrap, Actishield Cf |
| Organogenesis INC. | $304.51 | 2019-2025 | Affinity |
| Paragon 28, INC. | $242.02 | 2023-2024 | Portfolio, Jaws |
| Smith+Nephew, INC. | $183.95 | 2022-2025 | Grafix Pl, Oasis |
| Wright Medical Technology, INC. | $144.58 | 2019-2020 | |
| Cook Medical LLC | $122.20 | 2021 | |
| Integra Lifesciences Corporation | $91.63 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $54.74 | 2019 | |
| Celularity INC. | $40.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $34.39 | 2023-2025 | Nuzyra |
| Depuy Synthes Sales INC. | $21.87 | 2019 | |
| Cashflow Solutions, LLC | $20.25 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Bioventus LLC | $15.11 | 2025 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $14.54 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Federico Auger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.